Product Information
PRASUGREL 5 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.2957 per EA under NDC 16729027210. Its NADAC has been published 379 times since Feb 20, 2019.
FDA first approved this application on Feb 2, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Prasugrel market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729027210
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
PRASUGREL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205987FDA Approved
2/2/2018
TE Code
AB
On Market Since
1/16/2019
Pharmacological Classes
Price Statistics
The NADAC for PRASUGREL 5 MG TABLET has been published 379 times since Feb 20, 2019, and over the history we have for it it has declined 42.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2957 per EA |
|---|---|
| All-time high | $0.6953 (Apr 15, 2020) |
| All-time low | $0.2539 (May 22, 2024) |
| 52-week high | $0.3947 |
| 52-week low | $0.2893 |
| Median price | $0.4038 |
| Average price | $0.4152 |
| Largest weekly change | +60.6% (Feb 21, 2024) |
| Weeks tracked | 379 |
| Tracking since | Feb 20, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
+0.3%
1Y
-25.1%
3Y
-1.8%
5Y
-38.5%
All
-42.4%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 12% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PRASUGREL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PRASUGREL 5 MG TABLET, manufactured by Accord Healthcare Inc., is $0.2957 per EA (NDC 16729027210), effective May 20, 2026.
How has the price of PRASUGREL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for PRASUGREL 5 MG TABLET has declined 42.4%. It has been tracked across 379 weekly CMS publications since Feb 20, 2019.
What are the highest and lowest recorded NADAC prices for PRASUGREL 5 MG TABLET?
Since Feb 20, 2019, the NADAC for PRASUGREL 5 MG TABLET has ranged from a low of $0.2539 (May 22, 2024) to a high of $0.6953 (Apr 15, 2020), with a median of $0.4038 per EA.
Are there cheaper alternatives to PRASUGREL 5 MG TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PRASUGREL 5 MG TABLET, is $0.2616 per EA — about 12% below PRASUGREL 5 MG TABLET.
Who manufactures PRASUGREL 5 MG TABLET?
PRASUGREL 5 MG TABLET (NDC 16729027210) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.